Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Asbury

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
British Medical Journal|February 17, 1979
Retroperitoneal fibrosis after treatment with atenololM J Asbury
The Practitioner|December 1, 1980
Once daily combination therapy for hypertensionM J Asbury, F O Wells, N P Barker
European Journal of Pharmacology|September 1, 1973
The sites of action of bumetanide in manE Bourke, M J Asbury, S O'Sullivan, et al.
British Medical Journal|January 22, 1972
Bumetanide: potent new "loop" diureticM J Asbury, P B Gatenby, S O'Sullivan, et al.
Journal of Clinical Pharmacology|August 1, 1982
Effect of micronization on the bioavailability and pharmacologic activity of spironolactoneG T McInnes, M J Asbury, L E Ramsay, et al.
Clinical Pharmacology and Therapeutics|March 1, 1980
Activity of sulfur-containing intermediate metabolites of spironolactoneG T McInnes, M J Asbury, J R Shelton, et al.
British Journal of Clinical Pharmacology|March 1, 1980
The active constituent of spironolactone after acute administration in man [proceedings]G T McInnes, M J Asbury, J R Shelton, et al.
Clinical Pharmacology and Therapeutics|August 1, 1981
Bioassay of a new aldosterone antagonist and evaluation of a simple method of quantitative comparisonG T McInnes, J R Shelton, M J Asbury, et al.
British Journal of Clinical Pharmacology|March 1, 1982
Relative potency and structure activity relationships of aldosterone antagonists in healthy man: correlation with animal experienceG T McInnes, J R Shelton, L E Ramsay, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
British Medical Journal|February 17, 1979
Retroperitoneal fibrosis after treatment with atenololM J Asbury
The Practitioner|December 1, 1980
Once daily combination therapy for hypertensionM J Asbury, F O Wells, N P Barker
European Journal of Pharmacology|September 1, 1973
The sites of action of bumetanide in manE Bourke, M J Asbury, S O'Sullivan, et al.
British Medical Journal|January 22, 1972
Bumetanide: potent new "loop" diureticM J Asbury, P B Gatenby, S O'Sullivan, et al.
Journal of Clinical Pharmacology|August 1, 1982
Effect of micronization on the bioavailability and pharmacologic activity of spironolactoneG T McInnes, M J Asbury, L E Ramsay, et al.
Clinical Pharmacology and Therapeutics|March 1, 1980
Activity of sulfur-containing intermediate metabolites of spironolactoneG T McInnes, M J Asbury, J R Shelton, et al.
British Journal of Clinical Pharmacology|March 1, 1980
The active constituent of spironolactone after acute administration in man [proceedings]G T McInnes, M J Asbury, J R Shelton, et al.
Clinical Pharmacology and Therapeutics|August 1, 1981
Bioassay of a new aldosterone antagonist and evaluation of a simple method of quantitative comparisonG T McInnes, J R Shelton, M J Asbury, et al.
British Journal of Clinical Pharmacology|March 1, 1982
Relative potency and structure activity relationships of aldosterone antagonists in healthy man: correlation with animal experienceG T McInnes, J R Shelton, L E Ramsay, et al.
Pageof 1